Accessibility Menu
Hims & Hers Health logo

Hims & Hers Health(NYSE) HIMS

Market Cap$7.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)+203%
5 Year+288%
1 Year-38%
1 Month-12%
$31.59
+6.51%
+1.93Today
After hours$31.66+$0.07 (+0.22%)
Hims & Hers Health last closing stock price
MetricPriceDate
Last closeUSD 31.592026-08-07
Hims & Hers Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+13.76%USD 27.772026-07-31
1 month-12.42%USD 36.072026-07-08
3 month+11.74%USD 28.272026-05-08
Year to date-2.71%USD 32.472025-12-31
1 year-38.12%USD 51.052025-08-07
3 year+324.6%USD 7.442023-08-08
5 year+287.61%USD 8.152021-08-06
Since inception+202.65%USD 9.802019-09-13

Hims & Hers Health Financials at a Glance

Market Cap

$7.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.37B

Net Income (TTM)

-$13.24M

EPS (TTM)

-$0.08

P/E Ratio

-385.71

Dividend

$0.00

Beta (Volatility)

1.93 (High)

Price

$31.59

Volume

8,391,219.196

Open

$30.19

Previous Close

$31.59

Daily Range

$29.80 - $31.72

52-Week Range

$13.74 - $65.30

Estimated Earnings Date

Aug 10, 2026

HIMS News

Concerned person looking at a piece of paper.

Is Hims & Hers Health Stock in Trouble?

David Jagielski, CPAAug 3, 2026
TMF-Pills-Purple-StockVStock.png

Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?

Pamela KockJul 6, 2026
856 - HIMS

Great News: Wall Street Is Turning Bullish on This Troubled Telehealth Stock

Rick OrfordJun 5, 2026
4. Hims and hers

Is Hims & Hers Stock an Undervalued Stock to Buy?

Parkev Tatevosian, CFAJun 1, 2026
GettyImages-2148786851

Hims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign?

Jeff SiegelMay 15, 2026
HIMS

Is Hims and Hers Health Stock a Buy After Its Latest Dip?

Geoffrey SeilerMay 14, 2026
GLP-1 Semaglutide weight loss injector pens in a box

Why Hims & Hers Health Stock Just Crashed

Rich SmithMay 12, 2026
STOCK-MARKET-DAILY-ONLY-BullBear-Blue-Orange.png

Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program

Emma NewberyApr 21, 2026
Page 1

HIMS: Motley Fool Moneyball Superscore

73

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hims & Hers Health

Hims & Hers helps people get health products and doctors online. It simplifies finding treatments for hair loss and skin care. Customers use a website or app to manage wellness from home.

What is on the Menu?

  • Sexual Health: Treatments for reproductive wellness and sexual performance for men and women.
  • Hair Care: Prescription and over-the-counter solutions like minoxidil, shampoos, and conditioners to treat hair loss.
  • Weight Loss: Access to medications including GLP-1s, which are glucagon-like peptide-1 receptor agonists used to manage weight.
  • Dermatology: Personalized skincare products such as serums, moisturizers, and face washes for various skin conditions.
  • Mental Health: Telehealth consultations and support for individuals seeking mental health services.

Expanding the Digital Pharmacy

  • Acquired YourBio in January 2026 to add blood-sampling technology to its health platform.
  • Purchased Medici in November 2025 to enter the Canadian market and grow fulfillment capabilities.
  • Completed the acquisition of Zava in July 2025 to expand operations in the United Kingdom and Europe.
  • Bought manufacturing assets from C S Bio Co. in February 2025 to strengthen its supply chain.
  • Signed a deal in February 2026 to acquire Eucalyptus, an Australian digital health firm.

What Makes the Platform Stand Out?

The company uses a cloud-based system to connect a provider network with electronic medical records and pharmacy fulfillment. It operates across several international markets including the United Kingdom, Canada, and several European Union countries.

The Latest Numbers

  • Revenue grew to $608.1 million in Q1 2026, up 3.8% from the same period in 2025.
  • Gross profit reached $396.8 million in Q1 2026, down 7.9% from $430.7 million in Q1 2025.
  • Net loss was $92.1 million in Q1 2026, which worsened from a net income of $49.5 million in Q1 2025.
  • Free cash flow reached $53.0 million in Q1 2026, up 6% from the previous year.

Evolution of the Business

Hims & Hers has evolved from a wellness product seller into a global telehealth platform with its own pharmacy and lab capabilities. Recent international acquisitions and new weight loss offerings show a strategy focused on diversifying its healthcare services.

AI Generated • May 20, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

2,442

CEO

Andrew Dudum

Website

www.hims.com

Headquarters

San Francisco, CA 94123, US

HIMS Financials

Key Financial Metrics (TTM)

Gross Margin

67.64%

Operating Margin

1.32%

Net Income Margin

-0.56%

Return on Equity

-2.48%

Return on Capital

6.36%

Return on Assets

-0.58%

Earnings Yield

-0.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

231.46M

Volume

8.39M

Avg. Volume

18.51M

Financials (TTM)

Gross Profit

$1.60B

Operating Income

$31.25M

EBITDA

$30.06M

Operating Cash Flow

$283.66M

Capital Expenditure

-$207.82M

Free Cash Flow

$75.84M

Cash & ST Invst.

$750.88M

Total Debt

$1.13B

Hims & Hers Health Performance Analysis

Hims & Hers Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 526,916,00093.8%
20232023-12-31USD 872,000,00065.5%
20242024-12-31USD 1,476,514,00069.3%
20252025-12-31USD 2,347,637,00059.0%
Hims & Hers Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-7.0%
Q32025-09-309.9%
Q42025-12-313.1%
Q12026-03-31-1.6%
Hims & Hers Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.32-44.3%
20232023-12-31USD -0.11-65.0%
20242024-12-31USD 0.53N/A
20252025-12-31USD 0.51-3.7%
Hims & Hers Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-15.0%
Q32025-09-30-62.7%
Q42025-12-3126.2%
Q12026-03-31-600.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$608.10M

+3.8%

Gross Profit

$300.28M

-30.3%

Gross Margin

49.38%

N/A

Market Cap

$7.31BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.99M

N/A

Employees

2,442

N/A

Net Income

-$92.12M

-286.1%

EBITDA

-$79.60M

-215.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$750.88M

+132.7%

Total Debt

$1.13B

+1686.0%

Accounts Receivable

$149.62M

+2054.7%

Inventory

$84.71M

+11.3%

Long Term Debt

$1.13B

+1788.5%

Short Term Debt

$5.58M

+49.3%

Return on Assets

-0.58%

N/A

Return on Invested Capital

1.90%

N/A

Free Cash Flow

$53.03M

+6.0%

Operating Cash Flow

$89.36M

-18.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QGENQiagen N.V.
$42.30+1.37%
HQYHealthEquity, Inc.
$104.63+1.15%
ENSGThe Ensign Group, Inc.
$182.97+0.72%
TECHBio-Techne Corporation
$72.29+0.54%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$133.11+0.16%
TTDThe Trade Desk
$13.80-0.22%
NVDANvidia
$223.96+0.02%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$82.76+0.00%

Questions About HIMS

What is the current price of Hims & Hers Health?

Hims & Hers Health is trading at $31.59 per share.

What is the 52-week range for Hims & Hers Health?

Over the past 52 weeks, Hims & Hers Health has traded between $13.74 and $65.30.

How much debt does Hims & Hers Health have?

As of the most recent reporting period, Hims & Hers Health reported total debt of $1.13B.

How much cash does Hims & Hers Health have on hand?

Hims & Hers Health reported $222.27M in cash and cash equivalents in its most recent financial results.

What is Hims & Hers Health’s dividend yield?

Hims & Hers Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services